Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis

Journal of Experimental Medicine

Volumn 189, Issue 7, 1999, Pages 1033-1042

  Tuohy, Vincent K ^a   Yu, Min ^a   Yin, Ling ^a   Kawczak, Julie A ^a   Kinkel, R Philip ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Autoimmunity; Demyelination; Epitope spreading; Multiple sclerosis; Myelin proteolipid protein

Indexed keywords

PROTEOLIPID PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; CELL SPREADING; CONTROLLED STUDY; DEMYELINATING DISEASE; DEMYELINATION; EPITOPE MAPPING; FLOW CYTOMETRY; HELPER CELL; MOLECULAR RECOGNITION; MONONUCLEAR CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REGRESSION ANALYSIS;

ACUTE DISEASE; ADULT; ANIMALS; ANTIGENIC VARIATION; AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BRAIN; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNIZATION; IMMUNODOMINANT EPITOPES; MALE; MICE; MODELS, IMMUNOLOGICAL; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; MYELIN PROTEINS; MYELIN PROTEOLIPID PROTEIN; MYELIN-ASSOCIATED GLYCOPROTEIN; PEPTIDE FRAGMENTS; SELF TOLERANCE; SPINAL CORD; SPLEEN; TH1 CELLS;

EID: 0033526109     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.7.1033     Document Type: Article

References (56)

1. Alvord, E.C., Jr., M.W. Kies, and A.J. Suckling, editors. 1984. Experimental Allergic Encephalomyelitis - A Useful Model for Multiple Sclerosis. Alan R. Liss, New York.
2. Martin, R., H.F. McFarland, and D.E. McFarlin. 1992. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:153-187.
3. Steinman, L. 1996. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell. 85:299-302.
4. Lehmann, P.V., T. Fotsthuber, A. Miller, and E.E. Sercarz. 1992. Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature. 358:155-157.
5. McRae, B.L., C.L. Vanderlugt, M.C. Dal Canto, and S.D. Miller. 1995. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:75-85.
6. Yu, M., J.M. Johnson, and V.K. Tuohy. 1996. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease J. Exp. Med. 183:1777-1788.
7. Vanderlugt, C.L., and S.D. Miller. 1996. Epitope spreading. Curr. Opin. Immunol. 8:831-836.
8. Beck, R.W., P.A. Cleary, J.D. Trobe, D.I. Kaufman, M.J. Kupersmith, D.W. Paty, and C.H. Brown. 1993. The effect of corticosteroid for acute optic neuritis on the subsequent development of multiple sclerosis. N. Engl. J. Med. 329: 1764-1769.
9. Morrissey, S.P., D.H. Miller, B.E. Kendall, D.P. Kingsley, M.A. Kelly, D.A. Francis, D.G. MacManus, and W.I. McDonald. 1993. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Brain. 116:135-146.
10. Filippi, M., M.A. Horsfield, S.P. Morrissey, D.G. MacManus, P. Rudge, W.I. McDonald, and D.H. Miller. 1994. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology. 44:635-641.
11. Milner, R.J., C. Lai, K.-A. Nave, D. Lenoir, J. Ogata, and J.G. Sutcliffe. 1985. Nucleotide sequences of two mRNAs for rat brain myelin proteolipid protein. Cell. 42:931-939.
12. Macklin, W.B., C.W. Campagnoni, P.L. Deininger, and M.V. Gardinier. 1987. Structure and expression of the mouse myelin proteolipid protein gene. J. Neurosci. Res. 18:383-394.
13. Geysen, H.M., S.J. Rodda, T.J. Mason, G. Tribbick, and P.G. Schoofs. 1987. Strategies for epitope analysis using peptide synthesis. J. Immunol. Methods. 102:259-274.
14. Tuohy, V.K., Z. Lu, R.A. Sobel, R.A. Laursen, and M.B. Lees. 1989. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142: 1523-1526.
15. Mathisen, P.M., M. Yu, J.M. Johnson, J.A. Drazba, and V.K. Tuohy. 1997. Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J. Exp. Med. 186:159-164.
16. Kawczak J.A., P.M. Mathisen, J.A. Drazba, B. Fuss, W.B. Macklin, and V.K. Tuohy. 1998. Digitized image analysis shows diffuse abnormalities of normal appearing white matter during acute experimental autoimmune encephalomyelitis. J. Neurosci. Res. 54:364-372.
17. Tuohy, V.K., Z. Lu, R.A. Sobel, R.A. Laursen, and M.B. Lees. 1988. A synthetic peptide from myelin proteolipid protein induces experimental allergic encephalomyelitis. J. Immunol. 141:1126-1130.
18. Tuohy, V.K., and D.M. Thomas. 1995. Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice. J. Neuroimmunol. 56:161-170.
19. Greer, J.M., V.K. Kuchroo, R.A. Sobel, and M.B. Lees. 1992. Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice. J. Immunol. 149:783-788.
20. Kono, D.H., J.L. Urban, S.J. Horvath, D.G. Ando, R.A. Saavedra, and L. Hood. 1988. Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice. J. Exp. Med. 168:213-227.
21. Sakai, K., S.S. Zamvil, D.J. Mitchell, M. Lim, J.B. Rothbard, and L. Steinman. 1988. Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein. J. Neuroimmunol. 19:21-32.
22. Cross, A.M., G.A. Hashim, and C.S. Raine. 1991. Adoptive transfer of experimental allergic encephalomyelitis and localization of the encephalitogenic epitope in the SWR mouse. J. Neuroimmunol. 31:59-66.
23. Amor, S., N. Groome, C. Linington, M.M. Morris, K. Dommair, M.V. Gardinier, J.M. Matthieu, and D. Baker. 1994. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol. 153:4349-4356.
24. Folch, J., M. Lees, and G.H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:497-509.
25. + T cells compared. J. Immunol. 154:4309-4321.
26. Tuohy, V.K., M. Yu, B. Weinstock-Guttman, and R.P. Kinkel. 1997. Diversity and plasticity of self-recognition during the development of multiple sclerosis. J. Clin. Invest. 99: 1682-1690.
27. Poser, C.M., D.W. Paty, L. Scheinberg, W.I. McDonald, F.A. Davis, G.C. Ebers, K.P. Johnson, W.A. Sibley, D.H. Silberberg, and W.W. Tourtellotte. 1983. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:227-231.
28. Novotny, J., R.E. Bruccoleri, W.D. Carlson, M. Handschumacher, and E. Haber. 1987. Antigenicity of myohemerythrin. Science. 238:1584-1586.
29. Baxevanis, C.N., G.J. Reclos, C. Servis, E. Anastasopoulos, P. Arsenis, A. Katsiyiannis, N. Matikas, J.D. Lambris, and M. Papamichail. 1989. Peptides of myelin basic protein stimulate T lymphocytes from patients with multiple sclerosis. J. Neuroimmunol. 22:23-30.
30. Ota, K., M. Matsui, E.L. Milford, G.A. Mackin, H.L. Weiner, and D.A. Hafler. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 346:183-187.
31. + cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J. Immunol. 148:1359-1366.
32. Valli, A., A. Sette, L. Kappos, C. Oseroff, J. Sidney, G. Miescher, M. Hochberger, E.D. Albert, and L. Adorini. 1993. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J. Clin. Invest. 91:616-628.
33. + T cells from multiple sclerosis patients. J. Neuroimmunol. 46:33-42.
34. + T cells from multiple sclerosis patients. J. Neuroimmunol. 53:153-161.
35. Markovic-Plese, S., H. Fukaura, J. Zhang, A. Al-Sabbagh, S. Southwood, A. Sette, V.K. Kuchroo, and D.A. Hafler. 1995. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J. Immunol. 155:982-992.
36. Kerlero de Rosbo, N., R. Milo, M.B. Lees, D. Burger, C.C. Bernard, and A. Ben-Nun. 1993. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J. Clin. Invest. 92:2602-2608.
37. Tanguay, S., and J.J. Killion. 1994. Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells. Lymphokine Cytokine Res. 13:259-263.
38. Forsthuber, T., H.C. Yip, and P.V. Lehmann. 1996. Induction of TH1 and TH2 immunity in neonatal mice. Science. 271:1728-1730.
39. Altman, J.D., P.A.H. Moss, P.J.R. Goulder, D.H. Barouch, M.G. McHeyzer-Williams, J.I. Bell, A.J. McMichael, and M.M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science. 274:94-96.
40. Yu, M., R.P. Kinkel, B. Weinstock-Guttman, D.J. Cook, and V.K. Tuohy. 1998. HLA-DP: a class II restriction molecule involved in epitope spreading during the development of multiple sclerosis. Hum. Immunol. 59:15-24.
41. Soderstrom, M., H. Link, S. Fredrikson, and J.-B. Sun. 1994. Optic neuritis and multiple sclerosis: the T cell repertoires to myelin proteins and MBP peptides change with time. Acta Neurol. Scand. 90:10-18.
42. Zhang, J., C. Vandevyver, P. Stinissen, and J. Raus. 1995. In vivo clonotypic regulation of human myelin basic protein-reactive T cells by T cell vaccination. J. Immunol. 155:5868-5877.
43. Steinman, L., and P. Conlon. 1997. Viral damage and the breakdown of self-tolerance. Nat. Med. 3:1085-1087.
44. Tuohy, V.K. 1998. Optimizing the therapeutic potential of autoreactive T cells by genetic modification. J. Neuroimmunol. 90:10. (Abstr.)
45. Wucherpfennig, K.W., I. Catz, S. Hausmann, J.L. Strominger, L. Steinman, and K.G. Warren. 1997. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B cell and T cell epitopes. J. Clin. Invest. 100:1114-1122
46. Warren, K.G., I. Catz, and K.W. Wucherpfennig. 1997. Tolerance induction to myelin basic protein by intravenous synthetic peptides containing epitope P85 VVHFFKNIVTP96 in chronic progressive multiple sclerosis. J. Neurol. Sci. 152: 31-38.
47. Nicholson, L.B., J.M. Greer, R.A. Sobel, M.B. Lees, and V.K. Kuchroo. 1995. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity. 3:397-405.
48. Gaur, A., S.A. Boehme, D. Chalmers, P.D. Crowe, A. Pahuja, N. Ling, S. Brocke, L. Steinman, and P.J. Conlon. 1997. Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms. J. Neuroimmunol. 74: 149-158.
49. Pelfrey, C.M., L.R. Tranquill, S.A. Boehme, H.F. McFarland, and M.J. Lenardo. 1995. Two mechanisms of antigen-specific apoptosis of myelin basic protein (MBP)-specific T lymphocytes derived from multiple sclerosis patients and normal individuals. J. Immunol. 154:6191-6202.
50. Tanaka, H., K. Ota, M. Ikusaka, M. Ejima, and S. Maruyama. 1995. [Expression of Fas-antigen on T cells in multiple sclerosis]. Rinsho Shinkeigaku. 35:299-301. (Japanese.)
51. Schwartz, R.H. 1990. A cell culture model for T lymphocyte clonal anergy. Science. 248:1349-1356.
52. DeSilva, D.R., K.B. Urdahl, and M.K. Jenkins. 1991. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J. Immunol. 147:3261-3267.
53. Correale, J., W. Gilmore, J. Lopez, S.Q. Li, M. McMillan, and L.P. Weiner. 1996. Defective post-thymic tolerance mechanisms during the chronic progressive stage of multiple sclerosis. Nat. Med. 2:1354-1360.
54. van Parijs, L.V., V.L. Perez, A. Biuckians, R.G. Maki, C.A. London, and A.K. Abbas. 1997. Role of interleukin 12 and costimulators in T cell anergy in vivo. J. Exp. Med. 186: 1119-1128.
55. Vandenbark, A.A., G. Hashim, and H. Offner. 1989. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature. 341:541-544.
56. Offner, H., G.A. Hashim, and A.A. Vandenbark. 1991. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science. 251:430-432.